FI874823A0 - PHARMACEUTICAL COMPOSITION FOR ANALYSIS OF HYPERTENSION AND CONGESTIONAL EFFECTS. - Google Patents

PHARMACEUTICAL COMPOSITION FOR ANALYSIS OF HYPERTENSION AND CONGESTIONAL EFFECTS.

Info

Publication number
FI874823A0
FI874823A0 FI874823A FI874823A FI874823A0 FI 874823 A0 FI874823 A0 FI 874823A0 FI 874823 A FI874823 A FI 874823A FI 874823 A FI874823 A FI 874823A FI 874823 A0 FI874823 A0 FI 874823A0
Authority
FI
Finland
Prior art keywords
congestional
hypertension
analysis
effects
pharmaceutical composition
Prior art date
Application number
FI874823A
Other languages
Finnish (fi)
Other versions
FI874823A (en
Inventor
Helene Siegl
Robert Paul Hof
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI874823A0 publication Critical patent/FI874823A0/en
Publication of FI874823A publication Critical patent/FI874823A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI874823A 1986-11-03 1987-11-02 PHARMACEUTICAL COMPOSITION FOR ANALYSIS OF HYPERTENSION AND CONGESTIONAL EFFECTS. FI874823A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FI874823A0 true FI874823A0 (en) 1987-11-02
FI874823A FI874823A (en) 1988-05-04

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
FI874823A FI874823A (en) 1986-11-03 1987-11-02 PHARMACEUTICAL COMPOSITION FOR ANALYSIS OF HYPERTENSION AND CONGESTIONAL EFFECTS.

Country Status (25)

Country Link
KR (1) KR960005145B1 (en)
AT (1) AT397343B (en)
AU (1) AU615883B2 (en)
BE (1) BE1002063A4 (en)
CA (1) CA1314222C (en)
CH (1) CH677189A5 (en)
DE (1) DE3736505A1 (en)
DK (1) DK574087A (en)
ES (1) ES2010524A6 (en)
FI (1) FI874823A (en)
FR (1) FR2605885B1 (en)
GR (1) GR871680B (en)
HK (1) HK138893A (en)
HU (1) HU199681B (en)
IE (1) IE60496B1 (en)
IL (1) IL84343A (en)
IT (1) IT1212037B (en)
LU (1) LU87034A1 (en)
MY (1) MY102124A (en)
NL (1) NL8702502A (en)
NO (1) NO874539L (en)
NZ (1) NZ222401A (en)
PH (1) PH23249A (en)
PT (1) PT86062B (en)
SE (1) SE8704272L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (en) * 1988-05-28 1989-12-07 Hoechst Ag COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS WITH COLD CHANNEL MODULATORS AND THEIR USE IN MEDICINAL PRODUCTS
FR2733911B1 (en) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd PHARMACEUTICAL COMPOSITION FOR RENAL OR CARDIOVASCULAR DISEASES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (en) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen COMBINATION OF DIHYDROPYRIDINE WITH ACE INHIBITORS AND THEIR USE IN MEDICINAL PRODUCTS
DE3633496A1 (en) * 1986-10-02 1988-04-14 Hoechst Ag COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS WITH CALCIUMANTAGONISTS AND THEIR USE IN MEDICINAL PRODUCTS
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
PT86062B (en) 1990-11-07
AU8057687A (en) 1988-05-05
SE8704272D0 (en) 1987-11-02
DK574087A (en) 1988-05-04
CA1314222C (en) 1993-03-09
FR2605885A1 (en) 1988-05-06
ATA286987A (en) 1993-08-15
HK138893A (en) 1993-12-24
PH23249A (en) 1989-06-16
BE1002063A4 (en) 1990-06-12
SE8704272L (en) 1988-05-04
HUT47847A (en) 1989-04-28
NL8702502A (en) 1988-06-01
IT1212037B (en) 1989-11-08
MY102124A (en) 1992-03-31
IL84343A (en) 1993-07-08
NO874539L (en) 1988-05-04
ES2010524A6 (en) 1989-11-16
IL84343A0 (en) 1990-02-09
IT8748553A0 (en) 1987-10-30
AT397343B (en) 1994-03-25
IE60496B1 (en) 1994-07-27
DE3736505A1 (en) 1988-05-05
NZ222401A (en) 1991-04-26
CH677189A5 (en) 1991-04-30
KR960005145B1 (en) 1996-04-22
LU87034A1 (en) 1988-05-03
GR871680B (en) 1988-05-02
AU615883B2 (en) 1991-10-17
NO874539D0 (en) 1987-11-02
PT86062A (en) 1987-12-01
HU199681B (en) 1990-03-28
FI874823A (en) 1988-05-04
IE872951L (en) 1988-05-03
FR2605885B1 (en) 1993-09-10
DK574087D0 (en) 1987-11-02
KR880006197A (en) 1988-07-22

Similar Documents

Publication Publication Date Title
IT1231434B (en) INTRAVENOUS PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION.
SE8801813D0 (en) PHARMACEUTICAL COMPOSITION
DE10199066I1 (en) Pharmaceutical composition
FR2636532B1 (en) PHARMACEUTICAL COMPOSITIONS
FI895681A0 (en) PHARMACEUTICAL COMPOSITION FOER SYSTEMISK TRANSDERMAL TILLFOERSEL.
DK330287D0 (en) ANTI-INFLAMMATORY RELATIONSHIP AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
IT8922164A0 (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION
FI872733A0 (en) PHARMACEUTICAL COMPOSITION.
FI872313A0 (en) PHARMACEUTICAL COMPOSITION.
DE3674040D1 (en) PHARMACEUTICAL COMPOSITIONS.
DK109887A (en) PHARMACEUTICAL PREPARATION CONTAINING ANTIBODIES
MC1878A1 (en) PHARMACEUTICAL COMPOSITIONS
FR2598617B1 (en) PHARMACEUTICAL COMPOSITION
IT1216139B (en) DIETARY COMPOSITION AND PROCEDURE FOR ITS PREPARATION.
DK652687D0 (en) PHARMACEUTICAL COMPOSITION comprising AZUMOL
FI874823A0 (en) PHARMACEUTICAL COMPOSITION FOR ANALYSIS OF HYPERTENSION AND CONGESTIONAL EFFECTS.
ATA133288A (en) PHARMACEUTICAL COMPOSITION
IT1197474B (en) BROMOFLUROETYLIPOFLUORITE AND PROCEDURE FOR ITS PREPARATION
IT8747977A0 (en) PHARMACEUTICAL COMPOSITIONS
DK37589A (en) PHARMACEUTICAL PREPARATION FOR 4-AROYLIMIDAZOLE-2-ONER
IT1224244B (en) ANOREXIZING PHARMACEUTICAL COMPOSITION INCLUDING 5-IDROSSITRPOFANO
IT1216894B (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION.
DE3667915D1 (en) PHARMACEUTICAL COMPOSITION.
BR1100961A (en) Pharmaceutical composition and composition
PT85350A (en) XYLOMETAZOIN-CONTAINING PHARMACEUTICAL PREPARATIONS

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG